Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features

David Ross, Paul Bartley, Jarrad Goyne, Alexander Morley, J Seymour, A Grigg

    Research output: Contribution to journal › Article › peer-review

    24 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease features'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Medicine and Dentistry

    Biochemistry, Genetics and Molecular Biology

    Immunology and Microbiology